It is a pharma private limited company based in Hubli, Karnataka, India, established in 2003.
2003 | Hubli, Karnataka, India | ActiveHicure Pharmaceuticals Private Limited, a active private limited company, was established on 23 June 2003 in Hubli, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24231KA2003PTC032145. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.45 Cr.
It upholds a compliant status. Its leadership includes Meghashyam Haridas Ladhad (Director), Rahul Ramchandra Nagmule (Director). Past directors included Bharatkumar Nathuram Patel, Ketan Harshadrai Shah, Meghashyam Haridas Ladhad. It holds no open charges and ₹11.37 Cr settled loans. Its latest AGM occurred on 23 September 2019, with the balance sheet filed on 31 March 2019. It is based at Sitaram Sadan Siddeshwar Nagar, Unkal, Hubli, Karnataka, 580031.
U24231KA2003PTC032145
032145
23 June 2003
₹1.50 Cr
₹1.45 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Hicure Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meghashyam Haridas Ladhad | Director | 17 Nov 2011 | Current |
| Rahul Ramchandra Nagmule | Director | 17 Nov 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Jul 2020 | Past |
| Pramod Abcsdd | Director | 22 Jul 2009 | Past |
| Pramod Abcsdd | Additional Director | 15 Sep 2012 | Past |
| Pramod Abcsdd | Additional Director | 15 Sep 2012 | Past |
| Pramod Abcsdd | Director | 15 Nov 2011 | Past |
| Pramod Abcsdd | Managing Director | 29 Sep 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hicure Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 26.69% decrease. The company also saw a substantial improvement in profitability, with a 26.7% increase in profit. The company's net worth observed a substantial decline by a decrease of 306.57%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Hicure Pharmaceuticals had a promoter holding of 29.56% and a public holding of 70.44%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹113,680,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Sep 2016 | Syndicate Bank | ₹6.50 M | Satisfied |
| 05 May 2016 | Others | ₹1.00 Cr | Satisfied |
| 05 Dec 2014 | Syndicate Bank | ₹3.75 Cr | Satisfied |
| 04 Feb 2013 | Hdfc Bank Limited | ₹2.65 Cr | Satisfied |
| 01 Feb 2013 | Hdfc Bank Limited | ₹2.65 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Hicure Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hicure Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hicure Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Hicure Pharmaceuticals Private Limited last Annual general meeting of members was held on 23 Sep 2019 as per latest MCA records. was completed.
Progress on Hicure Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Bangalore. was documented.
The activity A charge registered on 22 Sep 2016 via Charge ID 100060820 with Syndicate Bank was fully satisfied on 05 Oct 2018. was completed.
A charge registered on 05 May 2016 via Charge ID 100049813 with Others was fully satisfied on 05 Oct 2018. was recorded as a recent event.
Progress on A charge registered on 05 Dec 2014 via Charge ID 10536640 with Syndicate Bank was fully satisfied on 05 Oct 2018. was documented.
The activity A charge with Syndicate Bank amounted to Rs. 0.65 Cr with Charge ID 100060820 was registered on 22 Sep 2016. was completed.
The CIN of Hicure Pharmaceuticals Private Limited is U24231KA2003PTC032145.
Hicure Pharmaceuticals Private Limited is headquartered at Sitaram Sadan Siddeshwar Nagar, Unkal, Hubli, Karnataka, 580031.
Hicure Pharmaceuticals Private Limited was incorporated on 23 June 2003.
The current directors of Hicure Pharmaceuticals Private Limited are
The primary industry of Hicure Pharmaceuticals Private Limited is Manufacturing.
Hicure Pharmaceuticals Private Limited is unlisted.
The authorized capital of Hicure Pharmaceuticals Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.45 Cr.
The compliance status of Hicure Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX